Abstract Library

#4558 Prognostic impact of primary tumour location after resection of neuroendocrine liver metastases from gastroenteropancreatic tumours

Introduction: Little evidence however exists regarding the prognostic impact of localisation of the primary tumour in case of neuroendocrine liver metastasis (NELM).

Conference:

Presenting Author: Coppa J

Authors: Simonotti N, Coppa J, Maspero M, Paoletti M, Pezzoli I,

Keywords: neuroendocrine liver metastasis, liver resection, hepatic surgery, pancreatic net, gastroenteropancreatic neuroendocrine tumour,

#3508 Liver transplantation for metastatic neuroendocrine tumors: Time to extend criteria?

Introduction: Liver transplant (LT) might be considered in patients with liver-only neuroendocrine metastases (NELM), but controversy continues surrounding patient selection.

Conference:

Presenting Author: Ross R

Authors: Rossi R, Maspero M, Coppa J, Sposito C, Bhoori S,

Keywords: neuroendocrine tumor, neuroendocrine liver metastasis, liver transplant,

#3506 Different patterns of recurrence after liver resection and transplantation for metastatic neuroendocrine tumors. Single center ecperience

Introduction: Liver metastases (NELM) occur in nearly half of NET pts, 80%are unresectable, and affect their prognosis. Surgery remains the most effective option; curative liver resection (LR) and liver transplantation (LT) offer the best long-term outcomes with difficult to show outcome differences due to the long course of the disease. The risk of tumor recurrence is considerable after both approaches.

Conference:

Presenting Author: Coppa J

Authors: Coppa J, Rossi R, Bongini M, Maspero M, Sposito C,

Keywords: liver metastasis, surgery, liver transplantation, recurrence,

#3374 Gastric metaplasia and duodenal neuroendocrine neoplasms: True causality or simple coincidence?

Introduction: Duodenal neuroendocrine neoplasms (dNENs) are heterogeneous tumors, whose natural history is poorly known. Duodenal gastric metaplasia (DGM) is considered to be a precancerous lesion which is generally related to chronic inflammation as first sign. No data are available regarding its possible role as a risk factors for dNEN occurrence.

Conference:

Presenting Author: Rossi R

Authors: Rossi R, Milanetto A, Andreasi V, Campana D, Coppa J,

Keywords: duodenal neuroendocrine neoplasm, gastric metaplasia,

#2792 Post-Transplant Recurrence of Neuroendocrine Tumors

Introduction: Recurrence after liver transplantation (LT) for metastases from NET is observed in 30-50% of cases at 5 years after LT but management is individualized

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author:

Authors: Monteleone M, Sposito C, Rossi R, Pusceddu S, Coppa J,

Keywords: Liver transplantation, Recurrence, Liver metastases,